Carnexiv is a prescription drug approved by the Food and Drug Administration (FDA) to temporarily replace oral Carbamazepine therapy in adults with generalized tonic-clonic seizures and some types of partial seizures and mixed seizure patterns. Carnexiv is also referred to by its drug name, Carbamazepine.
Carnexiv is a member of the dibenzazepine class of anticonvulsants. An anticonvulsant is a drug that prevents seizures. It is believed that Carnexiv works in cases of epilepsy by inhibiting nerve signals.
How do I take it?
Carnexiv is administered intravenously every six hours.
Carnexiv comes in the form of a single-use vial.
The FDA-approved label for Carnexiv lists common side effects including dizziness, drowsiness, headache, blurred or double vision, infusion site reaction or discomfort, and anemia.
Rare but serious side effects listed for Carnexiv include bone marrow suppression, liver damage, suicidal ideation and behavior, electrolyte imbalance, and severe and potentially fatal dermatological reactions.
For answers to frequently asked questions about exposure to Carbamazepine during pregnancy and breastfeeding, visit the experts at MothertoBaby.org.
For more details about this treatment, visit:
Carnexiv – Lundbeck